Cite
HARVARD Citation
Guidi, L. et al. (2019). Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. United European Gastroenterology journal. 7 (9), pp. 1189-1197. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guidi, L. et al. (2019). Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. United European Gastroenterology journal. 7 (9), pp. 1189-1197. [Online].